Coya Therapeutics (COYA) EPS (Weighted Average and Diluted) (2022 - 2025)
Coya Therapeutics (COYA) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.34 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) fell 88.89% to -$0.34 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.27 through Dec 2025, down 29.59% year-over-year, with the annual reading at -$1.27 for FY2025, 29.59% down from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.34 in Q4 2025 for Coya Therapeutics, down from -$0.13 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.15 in Q4 2023 to a low of -$1.55 in Q3 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.49 across 4 years, with a median of -$0.34 in 2025.
- Biggest five-year swings in EPS (Weighted Average and Diluted): surged 112.5% in 2023 and later crashed 220.0% in 2024.
- Year by year, EPS (Weighted Average and Diluted) stood at -$1.2 in 2022, then soared by 112.5% to $0.15 in 2023, then plummeted by 220.0% to -$0.18 in 2024, then tumbled by 88.89% to -$0.34 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for COYA at -$0.34 in Q4 2025, -$0.13 in Q3 2025, and -$0.36 in Q2 2025.